ABSTRACT: Background: Bladder tumors are rare in children. Their clinical manifestations are similar to those found in adults. Only pathological examination of the lesion can confirm the diagnosis.

Urothelial carcinoma is the most common bladder cancer, with stage 1 indicating early-stage disease confined to the bladder lining. Diagnosis involves urinalysis, cystoscopy, TURBT, and imaging to ...

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...

Here are the takeaways from The New York Times Times Magazine article on how the cancer-research system, which has helped save millions of lives, is under threat in one of its most productive moments.

TORONTO — Five-year survival rates for people with lung cancer have doubled since the 1990s, but the disease still kills more patients than any other type of cancer, a Statistics Canada report said on ...

The 'Real Housewives of Beverly Hills' alum opened up about the emotional toll of living with cancer and how her dad, John Mellencamp, lends his support Courtesy of The Jamie Kern Lima Show Teddi ...

Amid the "highs and lows" of her cancer battle, Teddi Mellencamp is seeing a bright future. Asked about her prognosis on the July 29 episode of "The Jamie Kern Lima Show," the 44-year-old daughter of ...

Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC). Radical nephroureterectomy with an ipsilateral bladder cuff is the ...

Nat Clin Pract Urol. 2007;4(8):432-443. JD Raman is a Chief Resident in Urology and DS Scherr is an Assistant Professor of Urology at the New York Presbyterian Hospital Weill Cornell Medical Center, ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...

Traws Pharma published promising data on rigosertib for treating RDEB-associated SCC, showing an 80% response rate in clinical trials. The company is actively seeking development and commercialization ...